Navigation Links
Failing Heart Failure Patients

Australian teaching hospitals may be putting heart failure patients at further risk through a reluctance to prescribe them life-saving cardiovascular drugs.//

A recent study, published in the latest edition of the Medical Journal of Australia, evaluated the use of cardiovascular medications in patients with and without heart failure after a myocardial infarction (MI), otherwise known as a heart attack.

“Heart failure is a common and potentially lethal complication of MI, conferring a four-to-fivefold increase in mortality,” says Professor Henry Krum, co-author of the study and head of the NHMRC Centre of Clinical Research Excellence in Therapeutics at Monash University in Melbourne.

He says cardiovascular medication reduces the risk of disease and death in affected patients, but it is not known whether evidence-based prescribing occurs in Australian teaching hospitals.

Of the 479 patients admitted for MI who participated in the study, 116 had heart failure at some point during their hospitalisation.

But the MI patients were significantly less likely to be prescribed some types of cardiovascular medication than patients without heart failure.

Prof Krum says recent analyses have confirmed that some MI patients do derive substantial benefit from proven heart failure therapies, and their use should therefore be encouraged.

However he noted that the low prescribing rates may be explained by concerns over low blood pressure and greater clinical instability in patients with heart failure.

“In managing patients with heart failure, … the net benefit of multiple agents has to be weighed against the risks and the possibility of adverse events and drug interactions,” says Prof Krum.

“Patients with heart failure receive fewer life-saving drug therapies compared with those who do not have heart failure. These deficiencies in prescribing may lead to substantial increases in [cardiovascular] events in these patients.

“Given the absolute benefit of drug therapy in patients with heart failure after MI, our findings suggests the potential for suboptimal prescribing [exists] in Australian teaching hospital pracice.”
'"/>




Related medicine news :

1. College Student Commits Suicide After Failing In HSC Exams
2. "Serious Failings" Led To Spread Of Lethal Hospital Bug
3. New Device May Help Heal A Failing Heart
4. Special Exams to Help Failing Medical Students
5. Is There Any Clinical Benefit to Staying on a Failing Regimen?
6. One in Three Heart Attack Patients Have No Chest Pains
7. Epileptic Seizures Can Be Due to Heart Problem
8. Bypass Heart Surgery Performed Without General Anesthesia
9. New CPR Guidelines issued by Heart Association
10. White Cells Count Can Predict Heart Attack Death Risk
11. Vitamins-The answer to Heart Disease?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology: